与「AnswerMe」相关的搜索结果

#AKMU# 3rd MINI ALBUM [LOVE EPISODE] Official Audio Videos are now available on YouTube. 🎧 케익의 평화 (Peace of Cake) :  🎧 답답해 (Answer Me) :  #악뮤# #3rdMINIALBUM ##LOVE_EPISODE# #케익의평화# #PeaceofCake# #답답해# #AnswerMe#

25 years later, we remember the lives lost, honor the heroes who answered the call, and stand with all those whose lives were forever changed by September 11, 2001. never forget. 🇺🇸

Amazing update! Thanks to this incredible audience, @SpaceX has just fulfilled another one of Liv Perrotto's final wishes. I spoke with her mother @rebeccaperrotto earlier this year, and she shared the list of questions that Liv planned to ask @elonmusk just days before she passed away from cancer. After this audience made that post go viral, @elonmusk answered every one of them, including whether he would make Asteroid, the space-loving Shiba Inu she designed, the mascot for SpaceX. Well now, SpaceX has just added an official plush of Asteroid to their website! YOU played a huge role in bringing Liv's story to light and making this happen. Thank you!

Governor Jeff Landry talks about SpaceX’s historic Louisiana expansion: “The SpaceX folks are just unbelievable...The President issued an executive order that basically stated that we wanted the country to get to 1,000 launches by 2030...@elonmusk answered that. He understands that in order for us to beat China, we have to build launch sites of this scale. And the great thing about it in Louisiana is it is going to create enormous opportunities in a state that always desperately has needed it.”

At midnight on February 6th, earlier this year, the doorbell to our apartment rang. The doorbell was followed by a pounding on the door. I answered the door and a security person in our building handed me his phone. It was my oldest daughter Eloise. She had found my 26-year-old daughter unconscious on the floor of her apartment and had called 911. The EMT team was already there, but they did not know what was wrong with Lucy or to which hospital they would take her. I threw on some clothes and jumped in an Uber heading east toward Brooklyn. (Lucy lived alone in Williamsburg.) On the way, I learned that they were taking her to Elmhurst, a City trauma hospital in Queens. I arrived about five minutes after the ambulance to join Eloise, Lucy’s mom, and a friend, and waited to learn what was wrong. After about 15 minutes, I asked a nurse where she was. I looked over his shoulder to his computer. Next to her name, it said “non-responsive.” I walked into the emergency room and wandered around looking for her until I found her unconscious on a gurney surrounded by several doctors and nurses. By about 2:30am with the results from a CAT scan, Lucy’s doctors had determined that she had a massive brain hemorrhage and would need an emergency hemicraniectomy to release the pressure on her brain and remove the blood from the hemorrhage. I called our wonderful friend and family doctor Eddie Fisher and explained what was going on. He woke up Josh Bederson, Chairman of Neurosurgery at Mount Sinai, to find out more about Zach Hickman, the neurosurgeon on call that night. Dr. Bederson said Hickman was an excellent surgeon, which was comforting as we had no choice. The surgery to save Lucy’s life began around 3:15am and finished around 5:30am. It was successful. The following day, I joined Lucy in an ambulance while she was being transferred to Mount Sinai on Madison Avenue. Later that day, we determined from Lucy’s Oura ring that her hemorrhage had occurred around 9am, which meant that more than 19 hours had passed from the time of the hemorrhage to the completion of the surgery to release the pressure on her brain (I only wish @ouraring had an alert for this kind of a medical event. Imagine it could call a family member if the wearer doesn’t cancel the alert). I later learned that the standard of care is not to do surgery to save a patient with a large brain bleed if more than five hours have passed since the hemorrhage. Even when the surgery is done, I was told that the likely outcome for the patient is a few months in a nursing home and death from pneumonia. When I met Lucy’s doctors, I did my best to inspire them: “Let’s see what can be accomplished if we give her the best care possible and we invest unlimited resources to restore her to life.” And I promised that whatever we learned we would make available to everyone. Dr. Chris Kellner, her neurosurgeon, and Dr. David Putrino, Director of Rehabilitation Innovation for the Mount Sinai Health System have led Lucy’s care team since that day. Words cannot describe the remarkable and compassionate care that she has received beginning with the EMT team and then from nurses, doctors, therapists, and the army of people who have worked to save her and return her to life. To this day, we have a daily Zoom where we discuss her progress and make adjustments to her care. While her care and oversight have been incredible, the learnings for the Mount Sinai team have also been elucidating and will assist in the care of many others. Lucy began in a bad place. She was in a coma for several weeks and then awoke not being able to breathe on her own, unable to walk, see or speak. Over the last six months, she has recovered her cognition – she understands everything including her circumstance – is able to walk a hundred or more steps at a time with assistance, is making progress with sounds, vowels and consonants and the beginnings of speech, but she remains unable to see. Each day, she makes a little progress, and daily progress compounds. Every day I tell her that she just needs to make a little progress and it won’t be long before she is back. We remain optimistic that Lucy will return to normal function. It will likely take years, but I believe it is only a matter of time, hard work, and technological progress, along with some, and perhaps a lot, of divine intervention. Many people have been praying for Lucy and we are incredibly grateful for the prayers and remarkable support she has received. Lucy’s friends have been with her every day since the beginning, and their presence and friendship have saved her life and helped to rebuild and maintain her spirit. And on a very positive note, Lucy’s challenge has brought together our entire modern family who have all been incredibly devoted to her care and recovery. Lucy's vision and other faculties may require some form of brain computer interface, work that is underway at Neuralink, Precision Neuroscience, Science, Synchron, Nudge, and other companies in the space. If you are going to have a devastating brain injury, now is the best time in history for that to happen. We are living in a world when you can be confident that the blind will soon see again. We are going to do everything we can to help make that happen, including by assisting existing companies in the space. With respect to our promise to make Lucy’s care available to others, we have made good progress. In May, a real estate colleague made me aware of a 93% vacant, brand new, 400,000 square foot Class A+ purpose-built biotech facility on West End Avenue between 65th and 66th Streets that missed the market and was available for sale. The Pershing Square Foundation acquired the building 60 days later. We also put under contract an adjoining 130,000 square foot building at 320 West 66th Street that is currently being used by Saturday Night Live for studio space. The building has 35-foot ceilings with massive column-free spaces that can be converted into superb rehabilitation facilities. We will close on the SNL building in December. We are also acquiring an adjoining vacant lot with additional air rights. With just the existing zoning rights, we can add a 150,000 square feet for a total of 680,000 square feet, a lab footprint larger than Rockefeller University, and that’s without including the potential for an upzoning that would allow for substantially more buildable area on the site’s 3.4 acres with spectacular views of the Hudson. Our goal is to build the world’s greatest brain research, rehabilitation, recovery, human optimization, and longevity institute. We have named it The Ackman Oxman Institute or the AOI for lack of a better name, but also to reinforce the point that Neri and I and our family are all-in on the mission. The AOI will be patient-centric. It will not be an academic research institute that produces lots of papers, a Nobel Prize winner or two, but little if any results for patients. We will be laser-focused on cures, treatments, devices, rehabilitation and exercise equipment, and targeted and basic research with a goal of massively accelerating the time from idea to innovation to production to helping a patient. While the AOI will be a non-profit, it will have highly commercial instincts. The AOI will have its own venture funding and will work to develop innovations to create companies that we will seed, assist, and spinout to ensure technologies, treatments, techniques, and drugs get to patients as promptly as possible. On one 3.4 acre campus in what is still the greatest city in the world, we will do neurosurgery, neuroscience, rehabilitation, nutrition, BCI and device development, human trials, hyperbaric oxygen treatments, and life extension programs, and we will mandate and incentivize collaboration among the teams with no silos, politics, bureaucracy, or any other constraint that is inconsistent with the mission. Mount Sinai will be an important partner and deservedly so, but it won’t be our only hospital or medical school partner as we don’t believe any institution has a monopoly on the best ideas or the best talent. We don’t believe in exclusive relationships because that is not in the best interest of patients. Five years ago, we considered launching a brain institute inspired by Neri’s mom who sadly died from Alzheimer’s. We couldn’t make the math work as the real estate was too expensive and we believed it would be too difficult to recruit the best talent from universities to our effort. Since then, the real estate became available at a 70% discount, universities became a much less attractive place to work due to politics outweighing meritocracy, protests that disrupt learning, the curse of antisemitism, and a decline in funding. Fortunately, during the same time, I made sufficient personal economic progress to make the AOI possible. The advance of AI in the last few years will also enable us to greatly accelerate our mission. AI still has a lot to learn about human intelligence and the brain, and the AOI should be at the forefront of the interplay between the brain and AI. Today, I am making a public filing disclosing a gift from Neri and me of ~$400 million or 10,000,000 shares of Pershing Square Inc. (PS) to the AOI. It is very early days for Pershing Square so these shares are intended to anchor the long-term work of the AOI as the shares compound over time while generating what we expect will be a growing stream of quarterly dividends to fund the Institute. We will also be announcing an additional gift of similar and potentially greater size which won’t be in the form of Pershing Square stock to provide the AOI with the short- and intermediate-term runway necessary to enable it to achieve its goal of becoming a self-sustaining institute, which reinvests all of its revenues, royalties, and the economic rewards of company formation to advance the fields of brain health and human longevity. Neri and I have chosen to anchor the funding of the AOI to maintain vision alignment and limit the need for the organization to focus on fundraising. We expect the AOI to be the best-resourced brain, rehab, recovery, and longevity institute in the world. We are grateful to have been able to form a board which includes Dean Kamen (our generation’s Thomas Edison), George Yancopoulus (CEO of Regeneron), James Rothman (Nobel Laureate), Bernardo Sabatini (neuroscientist), Chris Kellner (neurosurgeon), Olivia Flatto (CEO Pershing Square Foundation), Neri Oxman, and myself. We have recently identified a CEO who we expect to announce by October along with other key hires, and are beginning searches for a Chief Scientific Officer, a Chief AI/Technology Officer, a Chief Operating Officer, a Chief Financial Officer, and other key leadership roles. If you find what we are building compelling and want to be part of the leadership team that creates and builds the AOI from a standing start, please send an email to: search@aoiinst.org with a short note as to why you believe you can help. Please include your best three ideas for the AOI along with a summary of your background and your most important accomplishments. We promise strict confidentiality to those expressing interest in working with us. We have learned from Lucy that the brain can recover from even catastrophic injury. There is so much more work to be done as the mind is a terrible thing to waste. For details from my Pershing Square SEC filing see:

Thoughts About Scaling Law Scaling, but not only of parameters. Every model release now ends with the same question: how many parameters? It isn't a question that can be answered on its own. Parameter count is only meaningful alongside three others — how much data you have, where you intend to spend your compute, and who will run the model, under what conditions. The field learned this the hard way. Kaplan et al. (2020) fit an exponent that told everyone to grow parameters faster than data — roughly 2.7:1 — and the industry complied: GPT-3, Gopher, MT-NLG. Hoffmann et al. (2022) redid the experiment across four hundred models and found the compute-optimal split is closer to 20 tokens per parameter, and that with sufficient compute the two should grow at the same rate rather than drifting apart. The error in the earlier fit compounded with every order of magnitude of compute, which is why the largest models of that generation were the most misallocated. The trillion-parameter round was, in retrospect, a detour the whole field took together and then reversed. Chinchilla wasn't the end either. It optimized training compute for models that would be trained once and evaluated. Today a model is called billions of times a day and inference dominates lifetime cost. Put inference into the objective and the optimum moves toward smaller models trained far longer — deliberate over-training, which is what Llama-2-7B and Gemma-2-9B were doing at roughly 290 and 889 tokens per parameter. Sparsity moved the target again. In a MoE model two quantities have to be kept apart: total parameters govern roughly how much the model can hold — knowledge, facts, the long tail — while activated parameters and effective depth govern roughly how far it can think, how many steps of a causal chain it can carry before it comes apart. A dense 20:1 ratio does not transfer. And the ratio isn't a single number at all: Roberts et al. (2025) find the optimal tokens-per-parameter is task-dependent, with memorization favoring more parameters and reasoning favoring more data. Follow-up work on MoE observes that at fixed TPP, pushing total parameters higher actually degrades reasoning, while activating more experts reliably helps it. This matters for what we are building toward. Finding a vulnerability is not a retrieval problem. It doesn't come from having memorized more CVEs; it comes from carrying a twenty-step chain of inference to the end without losing the thread. That capability does not live in total parameter count. Which brings us to this release. Total parameters appear to matter up to a threshold — enough to hold the world — after which additional capability comes from scaling elsewhere: effective depth per forward pass, and above all post-training. GLM-5.3 is our controlled experiment on that claim. Same base, same architecture, same total and activated parameters as GLM-5.2. One month of scaling long-horizon environments and RL. The gains are not marginal. Well, scaling has more than one dial. We turned the post-training one this time because it had the most slack left in it — not because the others are finished. Base model size, pretraining data, compute spent per forward pass: all of them are still on the table, and we will come back to each. What this experiment taught us is that the dials do not have to be turned together, and that the one worth turning next is rarely the one that was worth turning last. We are not done scaling. Next time, maybe mid-training, pre-training, and even more.

Afraid of heights? Claustrophobic? Prone to vertigo? If you answered yes to any of the above, there are some marvels of American engineering ... that you should probably stay away from. Our new Short explains.